FDA Drug Application (022421) for MIRAPEX ER by BOEHRINGER INGELHEIM

Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Application Number022421
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage0.375MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMIRAPEX ER
Active IngredientPRAMIPEXOLE DIHYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient PRAMIPEXOLE DIHYDROCHLORIDE3


Back to FDA Applications sponsored by BOEHRINGER INGELHEIM